Sequoia Financial Advisors, LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1599900
Akron, OH
Position in TAK
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$1,832,294
+$534,708 QoQ
Shares Held
98,936
+18.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sequoia Financial Advisors, LLC holds $18,289,856 across 14 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
169,700 | $5,111,364 | |
| 2 | ZTS |
Zoetis Inc.
|
20,927 | $2,473,780 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
163,060 | $2,258,381 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
98,936 | $1,832,294 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,424 | $1,437,383 | |
| 6 | VTRS |
Viatris Inc
|
99,279 | $1,341,259 | |
| 7 | HLN |
Haleon plc
|
102,062 | $1,021,640 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
4,849 | $638,807 |
All Filings in TAK
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,832,294 | 98,936 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,297,586 | 83,232 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,520,568 | 103,864 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,515,853 | 98,050 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $960,587 | 64,599 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $502,365 | 37,943 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $374,071 | 26,306 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $297,464 | 22,988 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $311,080 | 22,396 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $288,781 | 20,237 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $377,065 | 24,374 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $361,659 | 23,021 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $349,194 | 21,189 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $304,153 | 19,497 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $159,232 | 12,277 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $142,183 | 10,127 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $155,887 | 10,886 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||